“On 11 March, BLA hijacked the Jaffar Express train in an isolated mountainous region with improvised explosive devices and ...

Qure advances its pathology-shifting AMT-130 therapy for Huntington's disease; pivotal data and commercial launch prep target 2025 milestones.

The United Nations Security Council has raised alarm over the growing alliance between outlawed terrorist groups Balochistan Liberation Army (BLA) and Tehrik-e-Taliban Pakistan (TTP), calling it a ...

“On 11 March, BLA hijacked the Jaffar Express train in an isolated mountainous region with improvised explosive devices and ...

Denali Therapeutics Inc. (NASDAQ:DNLI) is a clinical-stage biopharmaceutical company headquartered in South San Francisco, ...

Cretostimogene stands out as a potential new standard for NMIBC, offering durable cancer control without surgery and ...

“We have just concluded a deal with the country of Pakistan, whereby Pakistan and the United States will work together on ...

Among reasons for the rejection, the agency cited a lack of US patient representation in the STARGLO trial assessing ...

On July 16, 2025, Bio-Thera Solutions, Ltd. (“Bio-Thera”) announced that the U.S. Food and Drug Administration (“FDA”) had accepted its ...

The Baloch Liberation Army (BLA) asserted that its members killed at least seven Pakistani soldiers during a military ...